Sign in
CompletedNo phase

Dobutamine for Management of Surgical Patients With Septic Shock

Key facts

Who runs it
First Affiliated Hospital of Zhejiang University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
584 people enrolled
Started
18 Jun 2024
Ended
15 Nov 2025
Type of study
Interventional, 2 groups
Treatments tested
  • Dobutamine
  • Norepinephrine
Record updated
4 December 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (9)Hide the full registry criteria

Who can take part

  • Patients with 18 years or older
  • Sugery patients with septic shock and the duration of opration is more than 1 hour

Who cannot take part

  • Allergy or known sensitivity to catecholamines(norepinephrine, dobutamine etc.)and genera anesthetics
  • Pregnancy
  • Long-term intakeβ-receptor blocker
  • patietns with dobutamine used within 72h before enrollment
  • Patients use Recombinant Human Brain Natriuretic Peptide(rhBNP), Levosimendan and Epinephrine within 72h before enrollment
  • Patients with hyperthyroidism
  • Patients and guardians refused to participate in this intervention clinical trial

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Septic shock is the last and most severe stage of sepsis and is defined by extremely low blood pressure, despite lots of intravenous fluids. The incidence of septic shock related cardiomyopathy was 10% to 70%. Besides, general anesthesia will inhibit the sympathetic nervous system, reduce myocardial contractility and aggravate cardiac dysfunction. No randomized controlled trials have yet explore the effects of dobutamine on clinical outcomes for patients with septic shock undergoing surgery under general anesthesia.

The 2 groups in the trial

  • Dobutamine, norepinephrineTreatment being tested

    Patients will be initiated on Dobutamine at 5 mcg/kg/min while continuous infusion of norepinephrine titrated to maintain a mean arterial pressure at 65mmHg or more

    Treatment: Dobutamine and Norepinephrine

  • NorepinephrineOther group

    Norepinephrine was titrated to maintain a mean arterial pressure at 65mmHg or more

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Director, Head of Anesthesiology and Critical Care, Principal Investigator, Professor
Publications
Record updated
4 December 2025